I'm suggesting that the one chance to impress the cancer research world lies in the perfection of this machine. Both SSI and MDA are in agreement on this and are willing to take whatever steps are required to insure that perfection.
You sound surprised by that. Seems obvious that since the Flynn acquisition years ago, they have been unable to prove it works. Otherwise big-time licensing agreements would have been forthcoming. So far not even the animal testing folks want it. Hopefully all that changes sometime soon.